AeroGen specializes in the development, manufacture and commercialization of products for the controlled delivery of drugs to the lungs, which is called pulmonary drug delivery. Drugs can be delivered via a fine mist, or aerosol, to the lungs to treat respiratory conditions such as asthma, or through the lungs to the bloodstream to treat diseases or conditions outside the lungs such as diabetes. AeroGen's core technology consists of a proprietary aerosol generator. When incorporated in our inhaler or nebulizer platforms, this aerosol generator delivers drugs in an aerosol of a predetermined particle size. We believe our delivery platforms will allow us to develop products delivering drugs formulated as liquids in solutions, suspensions or liposomes, from single-dose, multi-dose or patient-adjustable dosage forms. Products in development include our hand-held, breath-activated inhalers, nebulizers for home use and nebulizers for patients on mechanical ventilators.
Product / Technology type(s) covered:
- Drug delivery
United States of America